Related Experiment Videos
[Myocardiopathies (III). The classification and morphological patterns of hypertrophic myocardiopathy]
1Servicio de Cardiología, Hospital Juan Canalejo, La Coruña.
Insights
Hypertrophic cardiomyopathy presents diverse symptoms and forms. While obstructive patterns may guide treatment, neither obstruction nor hypertrophy severity reliably predicts patient prognosis, necessitating further research into genetic causes.
Area of Science:
- Cardiology
- Genetics
- Pathology
Context:
- Hypertrophic cardiomyopathy (HCM) exhibits significant clinical and morphological variability.
- Hemodynamic classification into obstructive and nonobstructive forms is clinically relevant for symptom management.
Purpose:
- To explore the clinical relevance of hemodynamic classification in hypertrophic cardiomyopathy.
- To discuss the limitations of morphological classification and the prognostic implications of hypertrophy.
- To highlight the potential of molecular genetic discoveries for understanding HCM etiology and pathogenesis.
Summary:
- HCM presents a wide spectrum of clinical and morphological features.
- Symptom severity in obstructive HCM correlates with the pressure gradient, guiding therapeutic strategies.
- However, the presence and severity of obstruction, as well as hypertrophy patterns, do not correlate with prognosis.
Impact:
- Understanding the genetic underpinnings of HCM is crucial for future classifications and therapeutic advancements.
- This research emphasizes the need for personalized approaches considering the heterogeneity of HCM.
- Future research should focus on integrating genetic data for a more comprehensive understanding of HCM.
Abstract:
Hypertrophic cardiomyopathy is characterized by a great variety of clinical manifestations and morphologic patterns. Hemodynamic classification in obstructive and nonobstructive forms may be clinically relevant since, although many patients have disabling symptoms in the absence of a pressure gradient, in the subset of patients who do have a gradient, symptom severity seems to relate its magnitude; this fact supports the use of some therapeutic approaches directed to reduce or eliminate obstruction. Nevertheless, the presence and severity of the gradient do not correlate with prognosis. On the other hand, from a morphological point of view, any classification will be limited by the great diversity of morphologic patterns, which include almost all forms of ventricular hypertrophy one could imagine, and by the possibility of significant changes in the severity and distribution of the hypertrophy during the life of the patient. In general, the degree and distribution of ventricular hypertrophy do not correlate with symptoms or prognosis. The identification of different molecular genetic abnormalities responsible for the development of hypertrophic cardiomyopathy, is expected to provide new insights in the etiology and pathogenesis of this disease, which should be considered in future classifications.